Physician profile
Brian D Laman
NPI 1396794152
$825.20
in general payments reported to CMS, 2019-2025
16 companies · $65.02 in 2025
The $65.02 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.56 · 2021: $86.82 · 2022: $89.01 · 2023: $34.33 · 2024: $482 · 2025: $65.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $297.77 | 2019-2025 | Mako, Insignia, Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $132.70 | 2023-2024 | Velys, Monovisc |
| Orthalign INC | $53.59 | 2024 | Orthalign Plus |
| Kci USA, INC. | $44.03 | 2021-2022 | |
| Orthofix Medical, INC. | $39.63 | 2024-2025 | Physio-Stim, Cervical-Stim |
| Organogenesis INC. | $36.62 | 2024 | |
| Si-Bone, INC. | $36.36 | 2021 | |
| Smith+Nephew, INC. | $27.80 | 2022-2024 | Grafix Pl, Stravix Pl |
| Bioventus LLC | $27.15 | 2021 | |
| Innovation Technologies INC | $25.00 | 2019 | |
| Gemini Mountain Medical, LLC | $21.57 | 2022 | |
| Glaxosmithkline, LLC. | $20.55 | 2022 | |
| Merck Sharp & Dohme LLC | $19.01 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.42 | 2024 | Farxiga |
| Skeletal Dynamics INC | $14.40 | 2023 | Implate, Align, Ijs |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Laman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.